✦ LIBER ✦

New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions?

✍ Scribed by Wilson, L.; Tang, J.; Zhong, L.; Balani, G.; Gipson, G.; Xiang, P.; Yu, D.; Srinivas, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN72 Cost Effectiveness Analysis of New

✍ Wilson, L.S.; Zhong, L.; Pon, V.; Srinivas, S.; Frear, M.; Nguyen, N.; Gong, C.; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Cost-Effectiveness Analysis of Abiratero

✍ Shibahara, H.; Shiroiwa, T.; Nakamura, K.; Shimozuma, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Cost Effectiveness Analysis Of Abiratero

✍ Persson, U.; Nilsson, S.; Prûtz, C.; Hjortsberg, C. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

PCN46 Cost-Efficacy Analysis of Licensed

✍ S. Ostalé; P. Ruiz 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB